FDA Device recall Z-1013-2023
Baxter Electrocardiograph, ELI 380 -DCS21
- FDA Device
- Class II
- terminated
- Published 2023-02-01
On 2023-02-01 the FDA classified a Class II recall of Baxter Electrocardiograph, ELI 380 -DCS21 by Baxter Healthcare, citing one ELI 380 Electrocardiograph intended to be used for a pilot program was shipped to a customer by mistake on 26 October 2022.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1013-2023 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-10-31 |
| Published | 2023-02-01 |
| Last updated | 2026-09-13 11:56 UTC |
| Company | Baxter Healthcare |
| Distribution | TX |
Product
Baxter Electrocardiograph, ELI 380 -DCS21
Reason
One ELI 380 Electrocardiograph intended to be used for a pilot program was shipped to a customer by mistake on 26 October 2022.
Identifiers
| code_info | Lot number 122420001706 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1013-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.